atovacuone
SpainDrugs containing this active substance
-
It is used to treat a lung infection called Pneumocystis pneumonia (PCP) in people who cannot take cotrimoxazole.
Form: suspension, oral
Active substance Dosage atovacuone 150 mg/ml Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to prevent and treat malaria, a disease transmitted by the bite of infected mosquitoes.
Form: tablets, film-coated
Active substance Dosage proguanil hydrochloride 100,000 P/P atovacuone 250,000 mg Manufacturer: Viatris Limited
-
It is used both to prevent and to treat malaria, a disease transmitted by the bite of infected mosquitoes.
Form: tablets, film-coated
Active substance Dosage atovacuone 250 mg proguanil hydrochloride 100 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to prevent malaria in children weighing between 11 and 40 kg and to treat malaria in children weighing between 5 kg and 11 kg.
Form: tablets, film-coated
Active substance Dosage atovacuone 62,5 mg proguanil hydrochloride 25 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to prevent malaria in adults and children weighing more than 40 kg, and to treat malaria in adults and children weighing more than 11 kg.
Form: tablets, film-coated
Active substance Dosage atovacuone 250,00 mg proguanil hydrochloride 100,00 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to treat a lung infection called Pneumocystis pneumonia (PCP) in people who cannot take cotrimoxazole.
Form: suspension, oral
Active substance Dosage atovacuone 750 mg Manufacturer: Glaxosmithkline S.A.